MBOT (Microbot Medical Inc) Gross Profit Margin

A stable team of unique robotics engineers provides Microbot Medical Inc. (MBOT) with a technological edge. Gross profit margins allow for the tracking of profitability trends, where the level of -413.60 reflects the current magnitude. The company's strategy is based on creating affordable systems for remote vascular surgeries. Growth is underpinned by patents for LIBERTY—the world's first disposable robotic platform, which minimizes infection risks and clinic costs.
Analytical breakdowns and data insights for company microbotmedical.com (MBOT)

Gross margin determines the profit share after deducting direct production costs, serving as a key indicator of cost management efficiency and the issuer's pricing power. By analyzing changes in gross margin, investors assess the ability of Microbot Medical Inc. (MBOT) to monetize robotic systems through long-term sales of high-margin consumables, which creates a sustainable cash flow by leveraging the technological lock-in of clinics to the brand.